The differential expression level of IκBα may influence activation of NF-κB transactivated genes [32]; therefore, promoter polymorphisms of the NFKBIA polymorphism may present another regulatory mechanism modulating NF-κB-mediated HCC carcinogenesis. This evidence concerns the gene NFKB1 and hepatocellular carcinoma.